Altered pre-lamin A processing is a common mechanism leading to lipodystrophy

Capanni, Cristina ; Mattioli, Elisabetta ; Columbaro, Marta ; Lucarelli, Enrico ; Parnaik, Veena K. ; Novelli, Giuseppe ; Wehnert, Manfred ; Cenni, Vittoria ; Maraldi, Nadir M. ; Squarzoni, Stefano ; Lattanzi, Giovanna (2005) Altered pre-lamin A processing is a common mechanism leading to lipodystrophy Human Molecular Genetics, 14 (11). pp. 1489-1502. ISSN 0964-6906

PDF - Publisher Version

Official URL:

Related URL:


Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPARγ) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein1(SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPARγ and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPARγ ligand activating the adipogenic program.

Item Type:Article
Source:Copyright of this article belongs to Oxford University Press.
ID Code:34703
Deposited On:11 Apr 2011 14:08
Last Modified:17 May 2016 17:35

Repository Staff Only: item control page